All type of patient: 5 trials - VA-I - VA II - HDFP - Barraclough - MRC (diu vs BB)
| High-dose diuretics vs beta-blockers | No demonstrated result suggested stroke (fatal and non fatal) by 56% (not demonstrated) | |
| High-dose diuretics vs control | No demonstrated result suggested cardiovascular events by 22% (not demonstrated) suggested Cardiovascular death by 19% (not demonstrated) suggested stroke (fatal and non fatal) by 36% (not demonstrated) suggested All cause death by 17% (not demonstrated) | |
| High-dose diuretics vs placebo | No demonstrated result suggested cardiovascular events by 67% (not demonstrated) suggested Cardiovascular death by 61% (not demonstrated) suggested stroke (fatal and non fatal) by 71% (not demonstrated) suggested Heart failure by 89% (not demonstrated) suggested All cause death by 56% (not demonstrated) |
-
About
-
Browse pathology
|
treatment
-
Site map
-
Credits
Made with in Lyon
-
Contact us
-
Privacy policy
-
